← SearchDEVELOPING KVX-053, A PTP4A3-TARGETED SMALL MOLECULE INHIBITOR, FOR ACUTE LUNG INJURY$1,991,213FY2025Defense Health AgencyDODKevirx Inc., Charlottesville VAInvestigatorsView source on USAspending →